Kane Biotech Inc (KNE) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.912x

Based on the latest financial reports, Kane Biotech Inc (KNE) has a cash flow conversion efficiency ratio of 0.912x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-680.61K ≈ $-492.35K USD) by net assets (CA$-746.54K ≈ $-540.04K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Kane Biotech Inc to measure how much of total assets are equity-financed.

Kane Biotech Inc - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Kane Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check KNE operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Kane Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kane Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Socket Mobile Inc NASDAQ:SCKT	0.099x
Eagle Pharmaceuticals Inc NASDAQ:EGRX	0.000x
Harris Technology Group Ltd AU:HT8	-0.192x
Marvel Discovery Corp V:MARV	0.000x
MT Malcolm Mines NL AU:M2M	-0.056x
New Zealand Coastal Seafoods Ltd AU:NZS	-0.786x
Alvo Minerals Ltd AU:ALV	-2.176x
Pembroke VCT PLC LSE:PEMB	-0.009x

Annual Cash Flow Conversion Efficiency for Kane Biotech Inc (2003–2025)

The table below shows the annual cash flow conversion efficiency of Kane Biotech Inc from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see Kane Biotech Inc market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CA$-746.54K ≈ $-540.04K	CA$-3.26 Million ≈ $-2.35 Million	4.361x	+72.80%
2024-12-31	CA$-1.63 Million ≈ $-1.18 Million	CA$-4.11 Million ≈ $-2.97 Million	2.523x	+919.19%
2023-12-31	CA$-8.41 Million ≈ $-6.08 Million	CA$-2.08 Million ≈ $-1.51 Million	0.248x	-66.34%
2022-12-31	CA$-4.14 Million ≈ $-2.99 Million	CA$-3.04 Million ≈ $-2.20 Million	0.736x	-49.65%
2021-12-31	CA$-1.57 Million ≈ $-1.13 Million	CA$-2.29 Million ≈ $-1.66 Million	1.461x	+139.86%
2020-12-31	CA$1.07 Million ≈ $777.45K	CA$-3.94 Million ≈ $-2.85 Million	-3.665x	-221.02%
2019-12-31	CA$836.81K ≈ $605.33K	CA$-955.37K ≈ $-691.10K	-1.142x	-139.40%
2018-12-31	CA$-984.84K ≈ $-712.42K	CA$-2.85 Million ≈ $-2.06 Million	2.898x	+488.15%
2017-12-31	CA$2.74 Million ≈ $1.98 Million	CA$-2.04 Million ≈ $-1.48 Million	-0.747x	+57.43%
2016-12-31	CA$1.35 Million ≈ $974.76K	CA$-2.36 Million ≈ $-1.71 Million	-1.754x	+39.34%
2015-12-31	CA$480.25K ≈ $347.40K	CA$-1.39 Million ≈ $-1.00 Million	-2.891x	-265.11%
2014-12-31	CA$1.32 Million ≈ $958.43K	CA$-1.05 Million ≈ $-758.95K	-0.792x	+12.89%
2013-12-31	CA$1.28 Million ≈ $928.25K	CA$-1.17 Million ≈ $-843.79K	-0.909x	-84.75%
2012-12-31	CA$2.35 Million ≈ $1.70 Million	CA$-1.16 Million ≈ $-835.72K	-0.492x	-24.43%
2011-12-31	CA$2.38 Million ≈ $1.72 Million	CA$-940.30K ≈ $-680.20K	-0.395x	+41.91%
2010-12-31	CA$1.16 Million ≈ $841.74K	CA$-792.06K ≈ $-572.96K	-0.681x	-60.08%
2009-12-31	CA$1.80 Million ≈ $1.30 Million	CA$-764.26K ≈ $-552.85K	-0.425x	+40.87%
2008-12-31	CA$1.49 Million ≈ $1.08 Million	CA$-1.07 Million ≈ $-776.48K	-0.719x	-2.74%
2007-12-31	CA$1.14 Million ≈ $825.19K	CA$-798.38K ≈ $-577.53K	-0.700x	-18.27%
2006-12-31	CA$1.42 Million ≈ $1.03 Million	CA$-843.13K ≈ $-609.91K	-0.592x	+25.57%
2005-12-31	CA$1.02 Million ≈ $735.99K	CA$-808.87K ≈ $-585.12K	-0.795x	+32.63%
2004-12-31	CA$426.65K ≈ $308.63K	CA$-503.50K ≈ $-364.22K	-1.180x	-178.44%
2003-12-31	CA$955.27K ≈ $691.03K	CA$-404.87K ≈ $-292.88K	-0.424x	--

About Kane Biotech Inc

V:KNE Canada Biotechnology

Market Cap

$3.29 Million

CA$4.55 Million CAD

Market Cap Rank

#29296 Global

#1374 in Canada

Share Price

CA$0.03

Change (1 day)

+0.00%

52-Week Range

CA$0.03 - CA$0.05

All Time High

CA$0.40